Zantac and various other generic ranitidine products were recalled from the market earlier this week after discovering that the over-the-counter drug contained cancer-causing ingredients.
The ranitidine pills that were recalled include those distributed by Sanofi, the manufacturer of Zantac. Generic ones distributed by Dr. Reddy’s Laboratories were most affected by the call, though. They manufacture the generic version of the over-the-counter drug sold at retailers including Target, Walmart, CVS, Sam’s Club, and Walgreens.
What is Ranitidine?
Ranitidine is commonly used by consumers to treat heartburn. It’s a nonprescription alternative for acid indigestion. The prescription version of the drug is used to treat gastroesophageal reflux disease (GERD), various types of ulcers, systemic mastocytosis, esophagitis, and various chronic diseases.
The lots of the generic ranitidine most affected by the recall include any many bottles that have a September 2019 to June 2021 expiration date on them.
FDA Issues Statement on Ranitidine Products Being Carcinogenic
A spokesperson for the FDA notes that the manufacturer of these pills hasn’t yet received any reports of injuries or illnesses caused by this drug. They warn any users of these pills to consult with their doctor or pharmacist before discontinuing taking them to see if they recommend an alternative treatment.
Houston Zantac Injury Lawyers
Zantac and other ranitidine products are just one of many recalls of medications or drugs that occur each year here in the United States. If your health has declined after having taken this product, then you should first reach out to your physician and then a lawyer. An attorney can advise you of your right to file suit to recover compensation for your medical bills and any damages for pain and suffering.